102. ルビンシュタイン・テイビ症候群 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 4 / 薬物数 : 8 - (DrugBank : 0) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Culture OF lymphoblastoid line from blood sample
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Depakine
   CHU de bordeaux
      -   Phase 2   EUCTR2011-003784-30-FR   France
EX-vivo approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Functional involvement OF identified epigenetic alterations
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Generation OF induced pluripotent stem cells (ipsc) from fibroblasts obtained BY skin biopsy
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Histone acetylation profiles OF cells OF SRT patients with crebbp mutations
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
IN-vitro approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Sodium valproate
   University Hospital, Bordeaux
      2012   Phase 2   NCT01619644   France